Light to medium-depth peels, microdermabrasion, and combination resurfacing protocols — including aftercare and patient selection.
Effective acne management in an aesthetic practice begins with a systematic grading process. Clinicians assess lesion type, distribution, and inflammatory burden to place patients into mild, moderate, or severe categories. This grading informs the balance between topical, procedural, and systemic interventions. It also highlights patient expectations and the need for a realistic timeline. By documenting the baseline, the practitioner can track response and adjust the plan as the skin evolves.
Topical agents remain first-line for many patients, but the decision to add a procedural step such as microdermabrasion, chemical peel, or extraction depends on lesion morphology and patient tolerance. Systemic therapy is reserved for moderate to severe inflammatory acne, or when rapid control is required, and should be coordinated with the patient's primary care provider or dermatologist. The clinician must weigh the risk of antibiotic resistance, hormonal considerations, and potential side effects against the anticipated benefit. Procedural options can reduce lesion load and improve drug penetration, yet they require careful patient selection.
Choosing a chemical peel involves matching the agent's depth to the patient's skin type and Fitzpatrick classification. Superficial glycolic or lactic peels are appropriate for lighter skin and mild post-inflammatory hyperpigmentation risk, while medium-depth trichloroacetic acid may be needed for thicker lesions in higher Fitzpatrick types, provided the practitioner uses pre-treatment priming and post-peel photoprotection. The risk of post-inflammatory hyperpigmentation rises with deeper peels and darker skin, so the clinician must assess melanin content, recent inflammation, and sun exposure history before proceeding.
Comedonal extraction should be performed after gentle exfoliation to soften the follicular plug, and only when the lesion is ready to be expressed without excessive force. Scarring assessment, including atrophic and hypertrophic patterns, guides whether adjunctive modalities such as laser resurfacing or subcision are indicated later in the treatment course. Rather than a single-visit fix, the practitioner builds a sequenced plan that alternates between control of active lesions, barrier restoration, and scar remodeling. This staged approach allows for monitoring of adverse effects, adjustment of therapy intensity, and reinforcement of patient adherence to home-care regimens.
No live cohorts are scheduled for this workshop right now. Call 866-667-0720 for the next available date.
Tell us a bit about your goals and we'll match you to the right cohort, share pricing, and walk you through payment plans.
Tell us a bit about you and an MD Education advisor will reach out with pricing, dates, and cohort availability.
How do I grade acne severity for treatment planning?
Begin by counting inflammatory papules, pustules, nodules, and comedones in each facial region. Note distribution patterns such as central, perioral, or mandibular involvement. Use a standardized scale, mild (mostly comedones), moderate (mixed inflammatory and non-inflammatory lesions), or severe (numerous nodules or widespread inflammation). Document any scarring or post-inflammatory changes. This objective grading helps you decide whether topical monotherapy, procedural adjuncts, or systemic agents are needed and provides a baseline for measuring response over time.
When should I consider systemic therapy versus topical or procedural options?
Systemic therapy is generally considered for patients with moderate to severe inflammatory acne, rapid progression, or when lesions are unresponsive to optimized topical regimens after several weeks. It may also be indicated when the burden of disease threatens psychosocial wellbeing. Procedural options can be added to accelerate lesion clearance or improve drug penetration, but they do not replace the need for systemic control in severe cases. Coordination with the patient's primary care provider or dermatologist ensures appropriate monitoring of systemic side effects and avoids duplicate therapy.
How do I choose the appropriate chemical peel agent and depth for a given skin type?
Match the peel's strength to the patient's Fitzpatrick classification and the thickness of the target lesion. Superficial agents such as glycolic or lactic acid (20-30% concentration) are suitable for lighter skin types (I-III) and for treating mild hyperpigmentation or fine texture issues. Medium-depth peels like trichloroacetic acid (35-50%) may be required for deeper lesions in higher Fitzpatrick types (IV-VI) but demand pre-treatment priming with retinoids or hydroquinone and strict post-peel photoprotection. Always perform a test spot when uncertainty exists.
What precautions should I take to minimize post-inflammatory hyperpigmentation in darker Fitzpatrick skin?
First, assess recent inflammation and sun exposure; active lesions increase the risk of pigmentary changes after injury. Use the lowest effective peel concentration and limit depth, favoring superficial agents when possible. Pre-treat with topical depigmenting agents such as hydroquinone or azelaic acid for two to four weeks to stabilize melanin production. Ensure rigorous post-procedure sunscreen use (SPF 30 or higher) and advise patients to avoid heat and friction for several days. Monitor the skin closely during the healing phase and be prepared to intervene with topical lightening agents if early hyperpigmentation appears.
How do I incorporate comedone extraction safely into a procedural visit?
Begin with a gentle exfoliation, microdermabrasion or a light chemical peel, to soften the keratin plug. Assess each comedo for readiness; only express lesions that are visibly raised and have a clear opening. Use a sterile extractor with light pressure, moving in a controlled direction to avoid tearing the follicular wall. Apply a soothing post-extraction serum containing anti-inflammatory ingredients and reinforce barrier repair with a non-comedogenic moisturizer. Document any adverse reactions and schedule follow-up to evaluate healing and adjust future extraction frequency.
What are the scope-of-practice considerations for performing these procedures in an aesthetic setting?
Clinicians must verify that each intervention aligns with the regulations of their professional licensing board and the policies of their employing facility. Some jurisdictions limit the use of certain prescription-only agents, systemic medications, or deeper chemical peels to physicians or to providers with specific training. It is essential to maintain clear documentation of competency, obtain informed consent that outlines the procedure, potential risks, and alternative treatments, and to have a system for medical oversight or referral when a case exceeds the provider's authorized scope.
Why is hands-on practice important beyond video demonstration?
Video demonstrations convey visual steps but cannot replicate tactile feedback, tissue resistance, or the subtle variations encountered with different skin types. Hands-on practice allows clinicians to develop the motor skills needed for controlled pressure during extraction, to gauge the appropriate depth of a peel, and to adjust technique in real time based on patient response. It also provides an opportunity for immediate instructor feedback, correction of unsafe habits, and confidence building before treating actual patients.
